ANSTO’s $13.9 million to advance critical minerals processing

Processing of rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit following a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub. The Minister for Resources and Minister Madeleine King announced the funding for a research project to accelerate the…

ANSTO instrument finds radioactive ‘needle in a haystack’

Radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) were behind the successful detection and retrieval of a missing radioactive source in outback Western Australia. Working with the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Defence, and the Western Australia Department of Fire and Emergency Services (DFES), they located the miniscule-sized source…

Frontiers in additive manufacturing – ANSTO offers real time analysis of metal deposition systems

@AuManufacturing’s latest editorial series, Frontiers in Additive Manufacturing reveals a new capability developed at the Lucas Heights nuclear facility which will offer real-time information about the powder deposition process in metal additive manufacturing systems. The Australian Nuclear Science and Technology Organisation has boosted its additive manufacturing capabilities with the installation of a custom built Laser…

ANSTO to manufacture skin cancer treatment

Nuclear science and technology organisation ANSTO has been licensed as the Australian manufacturing partner of a new non-invasive treatment for non-melanoma skin cancer (NMSC). Radioisotope developer OncoBeta and ANSTO will establish local manufacturing of the company’s epidermal radioisotope therapy, Rhenium-SCT (Skin Cancer Therapy) for the treatment of non-melanoma skin cancer. ANSTO operates the OPAL nuclear…

Cyclotek and ANSTO to manufacture new radiopharmaceuticals

Cyclotek and ANSTO have announced the launch of a Joint Venture to establish Australia’s first GMP (Good Manufacturing Practice) theranostics production facility which will produce radiopharmaceuticals for both the diagnosis and treatment of cancer. The new company Applied Molecular Therapies Pty Ltd (AMT) will aim to establish a Therapeutic Goods Administration (TGA) approved, GMP manufacturing…

ANSTO to use neutrons to treat cancer

A international research group led by the Australian Nuclear Science and Technology Organisation (ANSTO) will accelerate development of Neutron Capture Enhanced Particle Therapy (NCEPT), a potential break-through technique for cancer treatment. The team, led by Dr Mitra Safavi-Naeini has been awarded a program grant from the Foundation for Australia-Japan Studies (FAJS) utilising neutrons produced at…